CDC42 and central nervous system cancer: Mechanistically, TRIM56 was found to interact with IQGAP1 to promote its K63-linked ubiquitination and inhibit degradative K48-linked ubiquitination at Lys-1230, thus promoting CDC42 activation in glioma cells.